English
Alkem Laboratories Q2 Results
- BSE: 539523
- NSE: ALKEM
- ISIN: INE540L01014
- Sector: Biotechnology & Drugs
BSE
5,632.75
7.55 (0.13%)
7.55 (0.13%)Volume5.00
Updated: Fri 12 Dec, 2025 | 09:40:57
NSE
5,6359.00 (0.16%)
9.00 (0.16%)Volume2.10 K
Updated: Fri 12 Dec, 2025 | 09:41:12
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹4,000.99 Cr.(17.17%)
- Operating Profit₹827.16 Cr.(22.74%)
- Profit After Tax₹765.06 Cr.(11.10%)
- Operating Margin20.67%(4.75%)
Note: Comparison is on YoY basis
Quarterly - Alkem Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3,173.83 | 2,706.84 | 17.25% | 2,740.75 | 15.80% |
| Depreciation/ Amortization | 93.61 | 87.68 | 6.76% | 78.91 | 18.63% |
| Operating Income | 827.16 | 664.30 | 24.52% | 673.92 | 22.74% |
| Net Income | 765.06 | 664.26 | 15.17% | 688.64 | 11.10% |
| Other Operating Expenses Total | 968.94 | 767.68 | 26.22% | 846.65 | 14.44% |
| Net Income Before Taxes | 895.34 | 770.60 | 16.19% | 780.26 | 14.75% |
| Total Revenue | 4,000.99 | 3,371.14 | 18.68% | 3,414.67 | 17.17% |
| Selling/ General/ Admin Expenses Total | 710.25 | 693.25 | 2.45% | 610.49 | 16.34% |
| Diluted Normalized EPS | 63.99 | 54.62 | 17.15% | 57.60 | 11.09% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.